RxSight (RXST) Other Operating Expenses (2020 - 2026)
RxSight's (RXST) quarterly Other Operating Expenses came in at $7.9 million in Q2 2026, down 7.01% on a YoY basis from $8.4 million in Q2 2025, and down 7.01% quarter-over-quarter from $8.4 million in Q2 2025.
Powered by 
Analysis
RxSight (RXST) Other Operating Expenses (2020 - 2026) Analysis & Trends
RxSight (RXST) has reported Other Operating Expenses for 3 consecutive years, with $7.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Operating Expenses fell 7.01% year-over-year to $7.9 million; the trailing twelve-month figure through Jun 2026 stood at $7.9 million (down 7.01% YoY), and the FY2020 full-year result was $7000.0, changed N/A from the prior year.
- Other Operating Expenses slipped to $7.9 million in Q2 2026 per RXST's latest filing, from $8.4 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $8.4 million in Q2 2025 and bottomed at $7.9 million in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | RxSight | 265.13 Mn | -139.12 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.86 Mn |
| Jun 30, 2025 | 8.45 Mn |
| Dec 31, 2020 | 7,000.00 |